NFATC3 and Bloom syndrome: Conversely, the expression levels of CCL2 and CXCL2 were markedly augmented in BLM-treated mice that received NFATc3+/+ donor macrophages (NFATc3+/+→ NFATc3+/+, NFATc3+/+→ NFATc3+/- groups) (Fig. 8E-H).